Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KND Biopharma is the biopharma/API division brand of KND Labs focused on supplying hemp-derived active pharmaceutical ingredients for pharmaceutical, research, clinical, and OTC product development. The business markets high-purity cannabinoid ingredients including CBD, CBC, CBN, CBG, and full-spectrum and broad-spectrum distillates. It appears to function primarily as a commercial ingredient supplier and manufacturing partner rather than as a therapeutic drug developer with a disclosed proprietary clinical pipeline. The broader KND organization emphasizes cGMP, FDA registration, ISO-compliant operations, formulation support, co-manufacturing, and global distribution across the U.S., Europe, and Asia. Based on available public information, KND Biopharma is best characterized as an active cannabinoid-API and contract manufacturing business within KND Labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KND Biopharma.